Level Bio AB (publ) (NGM:LEVBIO)
Sweden · Delayed Price · Currency is SEK 0.2640
+0.0100 (3.94%)
At close: Sep 3, 2026
Level Bio AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 18 | 21 | 19 | 26 | 47 | 163 | |
Market Cap Growth | -33.33% | 8.70% | -27.02% | -45.31% | -70.97% | 142.84% |
Enterprise Value | 18 | 19 | 18 | 21 | 42 | 156 |
Last Close Price | 0.26 | 0.30 | 0.28 | 0.41 | 0.75 | 2.57 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 3.80 | - | - | - | - | 31.60 |
PS Ratio | 0.53 | 0.63 | 0.75 | 0.99 | 1.38 | 3.71 |
PB Ratio | 2.72 | 32.20 | 4.52 | 2.48 | 2.38 | 7.37 |
P/TBV Ratio | 2.73 | - | 13.75 | 4.57 | 3.59 | 11.91 |
P/FCF Ratio | - | 25.01 | - | - | 16.92 | 100.19 |
P/OCF Ratio | - | 25.01 | - | - | 16.50 | 100.19 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.52 | 0.59 | 0.70 | 0.82 | 1.22 | 3.54 |
EV/EBITDA Ratio | - | - | - | - | - | 26.33 |
EV/EBIT Ratio | - | - | - | - | - | 29.60 |
EV/FCF Ratio | - | 23.09 | - | - | 14.97 | 95.70 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | - | 3.14 | 0.34 | 0.11 | 0.03 | 0.04 |
Debt / EBITDA Ratio | - | - | - | - | - | 0.15 |
Debt / FCF Ratio | - | 2.44 | - | - | 0.22 | 0.55 |
Net Debt / Equity Ratio | -0.01 | -0.76 | 0.08 | -0.24 | -0.36 | -0.22 |
Net Debt / EBITDA Ratio | 0.26 | 0.21 | -0.05 | 0.29 | 6.07 | -0.84 |
Net Debt / FCF Ratio | 0.20 | -0.59 | -0.07 | 0.46 | -2.59 | -3.05 |
Asset Turnover | 2.14 | 2.20 | 1.46 | 1.09 | 1.13 | 2.10 |
Inventory Turnover | 4.26 | 4.04 | 2.86 | 2.74 | 3.10 | 4.55 |
Quick Ratio | 0.33 | 0.66 | 0.71 | 1.08 | 1.83 | 1.83 |
Current Ratio | 0.70 | 0.99 | 1.08 | 1.66 | 2.61 | 2.66 |
Return on Equity (ROE) | 111.36% | -147.05% | -107.91% | -62.54% | -10.59% | 41.06% |
Return on Assets (ROA) | -5.58% | -14.81% | -29.32% | -25.40% | -4.79% | 15.66% |
Return on Invested Capital (ROIC) | -50.10% | -149.56% | -130.34% | -94.76% | -15.65% | 52.18% |
Return on Capital Employed (ROCE) | -19.90% | -320.80% | -177.30% | -87.90% | -11.00% | 22.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 26.34% | -17.25% | -41.70% | -36.63% | -4.70% | 3.16% |
FCF Yield | -2.11% | 4.00% | -23.63% | -21.22% | 5.91% | 1.00% |
Buyback Yield / Dilution | - | - | -7.89% | - | -7.41% | -20.00% |